Abstract

Silver nanoparticles (AgNPs) have garnered significant attention in recent years due to their unique physicochemical properties and versatile applications across various fields. This paper explores the emerging synergistic potential of silver nanoparticles in pharmaceutical production areas. The study investigates the multifaceted roles of AgNPs, including their antimicrobial, drug delivery, and diagnostic capabilities, which make them promising candidates for revolutionizing pharmaceutical manufacturing processes. By harnessing the intrinsic properties of AgNPs, pharmaceutical production can become more efficient, cost-effective, and environmentally friendly, ultimately leading to the development of safer and more effective pharmaceutical products.